"Growth Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS).
Descriptor ID |
D006131
|
MeSH Number(s) |
D27.505.696.377.450
|
Concept/Terms |
Growth Inhibitors- Growth Inhibitors
- Inhibitors, Growth
- Cell Growth Inhibitors
- Growth Inhibitors, Cell
- Inhibitors, Cell Growth
|
Below are MeSH descriptors whose meaning is more general than "Growth Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Growth Inhibitors".
This graph shows the total number of publications written about "Growth Inhibitors" by people in this website by year, and whether "Growth Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 2 | 0 | 2 |
1998 | 1 | 2 | 3 |
2000 | 0 | 1 | 1 |
2001 | 3 | 0 | 3 |
2002 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 1 | 1 | 2 |
2006 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2012 | 0 | 2 | 2 |
2014 | 1 | 0 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Growth Inhibitors" by people in Profiles.
-
Ingle K, LaComb JF, Graves LM, Baines AT, Bialkowska AB. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor. PLoS One. 2023; 18(11):e0294065.
-
Klaus CR, Iwanowicz D, Johnston D, Campbell CA, Smith JJ, Moyer MP, Copeland RA, Olhava EJ, Scott MP, Pollock RM, Daigle SR, Raimondi A. DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cells. J Pharmacol Exp Ther. 2014 Sep; 350(3):646-56.
-
Strong N, Millena AC, Walker L, Chaudhary J, Khan SA. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGF? effects on cell proliferation and migration in prostate cancer cells. Prostate. 2013 May; 73(6):624-33.
-
Rangwala F, Williams KP, Smith GR, Thomas Z, Allensworth JL, Lyerly HK, Diehl AM, Morse MA, Devi GR. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines. BMC Cancer. 2012 Sep 10; 12:402.
-
Martins M, Lazzell AL, Lopez-Ribot JL, Henriques M, Oliveira R. Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis. J Basic Microbiol. 2012 Aug; 52(4):487-91.
-
Maniccia AW, Lewis C, Begum N, Xu J, Cui J, Chipitsyna G, Aysola K, Reddy V, Bhat G, Fujimura Y, Henderson B, Reddy ES, Rao VN. Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins. J Cell Physiol. 2009 Jun; 219(3):634-41.
-
Perez-Torres M, Guix M, Gonzalez A, Arteaga CL. Epidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations. J Biol Chem. 2006 Dec 29; 281(52):40183-92.
-
Patisaul HB, Fortino AE, Polston EK. Neonatal genistein or bisphenol-A exposure alters sexual differentiation of the AVPV. Neurotoxicol Teratol. 2006 Jan-Feb; 28(1):111-8.
-
Patlolla AK, Tchounwou PB. Cytogenetic evaluation of arsenic trioxide toxicity in Sprague-Dawley rats. Mutat Res. 2005 Nov 10; 587(1-2):126-33.
-
Irizarry-Ram?rez M, Willson CA, Cruz-Orengo L, Figueroa J, Vel?zquez I, Jones H, Foster RD, Whittemore SR, Miranda JD. Upregulation of EphA3 receptor after spinal cord injury. J Neurotrauma. 2005 Aug; 22(8):929-35.